These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12174456)

  • 1. [Efficacy of hyaluronidaze in reducing vitreous opacites--preliminary report].
    Puchalska-Niedbał L; Millo B
    Klin Oczna; 2002; 104(2):135-7. PubMed ID: 12174456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of subconjunctival gentamicin after experimental cataract operations and traumatic lacerations.
    Yoshizumi MO; Leinwand M; Kim J
    J Ocul Pharmacol Ther; 1995; 11(4):519-25. PubMed ID: 8574815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes].
    Wang LF; Ma JX; Liu JZ; Cai SZ; Lu LC; Wang ZD
    Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit.
    Hikichi T; Kado M; Yoshida A
    Retina; 2000; 20(2):195-8. PubMed ID: 10783954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
    Kuppermann BD; Thomas EL; de Smet MD; Grillone LR;
    Am J Ophthalmol; 2005 Oct; 140(4):573-84. PubMed ID: 16125661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The difficulty of determining the route of intraocular penetration of gentamicin after subconjunctival injection in the rabbit.
    Barza M; Kane A; Baum J
    Invest Ophthalmol Vis Sci; 1981 Apr; 20(4):509-14. PubMed ID: 7216668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting response of vitreous hemorrhage after intravitreous injection of highly purified ovine hyaluronidase (Vitrase) in patients with diabetes.
    Bhavsar AR; Grillone LR; McNamara TR; Gow JA; Hochberg AM; Pearson RK;
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4219-25. PubMed ID: 18441312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of intravitreal hyaluronidase. A clinical and histologic study.
    Gottlieb JL; Antoszyk AN; Hatchell DL; Saloupis P
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2345-52. PubMed ID: 2242999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hyaluronidase injection on the vitreous humour of the rabbit.
    PIRIE A
    Br J Ophthalmol; 1949 Nov; 33(11):678-84. PubMed ID: 15392448
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
    Kuppermann BD; Thomas EL; de Smet MD; Grillone LR;
    Am J Ophthalmol; 2005 Oct; 140(4):585-97. PubMed ID: 16226510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of hyaluronidase on the rate of diffusion in the vitreous body in vivo; experiments with radioactive phosphate on rabbit eyes.
    CRISTIANSSON J
    Acta Ophthalmol (Copenh); 1955; 33(5):571-82. PubMed ID: 13301639
    [No Abstract]   [Full Text] [Related]  

  • 12. Intraocular dexamethasone penetration via subconjunctival or retrobulbar injections in rabbits.
    Bodker FS; Ticho BH; Feist RM; Lam TT
    Ophthalmic Surg; 1993 Jul; 24(7):453-7. PubMed ID: 8351091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fluorouracil and fluorouridine on protein synthesis in rabbit retina.
    Leon JA; Britt JM; Hopp RH; Mills RP; Milam AH
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1709-16. PubMed ID: 1698743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the antineoplastic agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in the aqueous and vitreous of rabbit.
    Ueno N; Refojo MF; Liu LH
    Invest Ophthalmol Vis Sci; 1982 Aug; 23(2):199-208. PubMed ID: 7096015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of enzymatic vitreolysis on the absorption of experimental vitreous hemorrhage. Preliminary report].
    Zagórski Z
    Klin Oczna; 1983 May; 85(5):197-9. PubMed ID: 6316024
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental data on methicillin tolerance and penetration into the eye media].
    Shchekotova IG
    Antibiotiki; 1975 Apr; 20(4):311-5. PubMed ID: 1211896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.
    Nomoto H; Shiraga F; Kuno N; Kimura E; Fujii S; Shinomiya K; Nugent AK; Hirooka K; Baba T
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4807-13. PubMed ID: 19324856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic vitreolysis combining the two enzymes plasmin and hyaluronidase.
    Gandorfer A; Kampik A
    Retina; 2005; 25(5):674; author reply 674-5. PubMed ID: 16077373
    [No Abstract]   [Full Text] [Related]  

  • 19. A minimally invasive jet injector for intravitreal and subconjunctival injection.
    Peyman GA; Hosseini K; Cormier M
    Ophthalmic Surg Lasers Imaging; 2012; 43(1):57-62. PubMed ID: 22251846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic vitreolysis with plasmin and hyaluronidase in diabetic rats.
    Zhi-Liang W; Wo-Dong S; Min L; Xiao-Ping B; Jin J
    Retina; 2009 Feb; 29(2):269-74. PubMed ID: 19050667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.